Literature DB >> 1233207

Plasma level and broncholytic effect of choline theophyllinate after a single dose of a press-coated tablet formulation.

K B Bülow, H Larsson, T Leideman.   

Abstract

The broncholytic effect and plasma concentrations of theophylline in 10 asthmatic patients were studied for 8 hours after a single dose of 600 mg choline theophyllinate in press-coated 200 mg tablets. Therapeutic concentrations of theophylline were rapidly achieved and the plasma peak averaged 10.4 mug/ml after 2 hours. The broncholytic effect was closely related to the plasma level of theophylline. The largest change was in FEV1, which was significantly increased 1 to 6 hours after the dose. No patient complained of adverse effects. A theophylline concentration of 7 mug/ml plasma was adequate for a broncholytic effect, but a higher level was required for a maximal response. The results provide a basis for further studies to establish a dosage schedule suitable for prolonged therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233207     DOI: 10.1007/bf00561559

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  4 in total

1.  Study of theophylline plasma levels after oral administration of new theophylline compounds.

Authors:  M TURNER-WARWICK
Journal:  Br Med J       Date:  1957-07-13

2.  An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues.

Authors:  J A SCHACK; S H WAXLER
Journal:  J Pharmacol Exp Ther       Date:  1949-11       Impact factor: 4.030

3.  Rapidly achieved plasma concentration plateaus, with observations on theophylline kinetics.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

4.  Plasma theophylline level and ventilatory function in chronic obstructive pulmonary disease during prolonged oral treatment with choline theophyllinate.

Authors:  K B Bülow; H Larsson; T Leideman
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

  4 in total
  3 in total

1.  Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.

Authors:  G E Marlin; B J Hartnett; N Berend; N B Hacket
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

2.  Plasma theophylline level and ventilatory function in chronic obstructive pulmonary disease during prolonged oral treatment with choline theophyllinate.

Authors:  K B Bülow; H Larsson; T Leideman
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

Review 3.  Ethylenediamine, profile of a sensitizing excipient.

Authors:  J Zuidema
Journal:  Pharm Weekbl Sci       Date:  1985-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.